Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib / Harrington, Patrick; Doores, Katie J; Saunders, Jamie; de Lord, Marc; Saha, Chandan; Lechmere, Thomas; Khan, Hataf; Lam, Ho Pui Jeff; Reilly, Amy O'; Woodley, Claire; Asirvatham, Susan; Dillon, Richard; Curto-Garcia, Natalia; Sullivan, Jennifer O'; Kordasti, Shahram; Raj, Kavita; Malim, Michael H; Radia, Deepti; Mclornan, Donal; Harrison, Claire; de Lavallade, Hugues. - In: BLOOD CANCER JOURNAL. - ISSN 2044-5385. - 12:4(2022). [10.1038/s41408-022-00651-3]
Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib
Kordasti, ShahramWriting – Review & Editing
;
2022-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
